STOCK TITAN
  1. Home
  2. Sec-filings
  3. DXR
  4. [EFFECT] DAXOR CORP SEC Filing

[EFFECT] DAXOR CORP SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 20, 2026 2:00 P.M.
Form: N-2
CIK: 0000027367
Company Name: DAXOR CORP
File Number: 333-281622

Source: View Original Filing on SEC EDGAR

Stock DXR logo
DAXOR CORP

NASDAQ:DXR

DXR Rankings

#5393 Ranked by Market Cap
N/A Ranked by Dividends

DXR Latest News

Jan 23, 2026
Daxor Corporation Announces $9 Million Registered Direct Offering
Nov 25, 2025
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
Oct 21, 2025
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
Oct 15, 2025
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25
Sep 30, 2025
Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA

DXR Latest SEC Filings

Jan 26, 2026
[8-K] DAXOR CORP Reports Material Event
Jan 23, 2026
[424B4] DAXOR CORP Prospectus Filed Pursuant to Rule 424(b)(4)
Jan 23, 2026
[424B3] DAXOR CORP Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 23, 2026
[8-K] DAXOR CORP Reports Material Event
Jan 22, 2026
[424B3] DAXOR CORP Prospectus Filed Pursuant to Rule 424(b)(3)

DXR Stock Data

63.44M
2.14M
56.64%
2.01%
0.77%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
NEW YORK